Tag: biomarkers
-
Biomarker-Guided Depression Drug Trial Underway
The first participant in a clinical trial received an experimental drug to treat patients with depression that express high levels of a stress-related protein.
-
Trial Identifies Biomarkers for Quick Concussion Test
A clinical trial reveals glycan compounds found in saliva and urine as indicators of traumatic brain injury, helping create a quick diagnostic for the condition.
-
Alzheimer’s Digital Biomarkers Project Gains New Funds
A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia.
-
Foundations Direct $5M for Neurodegenerative Tests
Two foundations are spending $5 million to develop new diagnostics for frontotemporal degeneration, an inherited neurodegenerative disorder and form of dementia.
-
Start-Up Analyzes Images to Determine Medical Condition
A new company provides a service that determines a person’s condition for disease treatments based on indicators derived from an analysis of huge medical-image databases.
-
FDA Approves 25 Precision Meds in 2018
An organization advocating for medicines addressing a person’s unique chemical composition rather than disease symptoms says U.S. regulators approved 25 of those drugs in 2018.
-
Trial Testing Breath Detection for Cancer
A clinical trial is recruiting participants to test a technology that analyzes exhaled breath for indicators of specific types of cancer.
-
FDA Approves Biomarker-Targeting Cancer Drug
The Food and Drug Administration yesterday approved a treatment for solid tumor cancers that focuses on specific cancer-causing genetic conditions rather than location of the cancer in the body.
-
Gates, Lauder Backing Early Alzheimer’s Biomarker Tests
A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up.
-
Immune Disease Precision Therapy Company Starts Up
An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe.